Skip to main content

FibroFix™ Cartilage, silk-based implant for cartilage repair and regeneration, introducing a new paradigm in osteoarthritis treatment.

Project description

New regenerative implant to prevent total knee replacement

Knee cartilage deterioration or injuries are often the cause of osteoarthritis. This chronic disease associated with pain, stiffness and severe disability decreases the quality of life and represents a serious economic burden for health systems. However, existing treatments such as total knee joint replacement are expensive and often involve complications. The EU-funded FibroFix Cartilage project proposes a regenerative orthopaedic implant that addresses the problem of large and/or osteoarthritic articular cartilage lesions in the knee. The silk-based implant is biostable and biocompatible, emulating cartilage function and supporting cartilage regeneration at a significantly lower cost than other solutions. The product allows prolonged use of the joint, increases mobility, reduces pain and postpones or prevents total knee replacement.

Call for proposal

H2020-EIC-SMEInst-2018-2020-3
See other projects for this call

Coordinator

ORTHOX LIMITED
Address
66 Innovation Drive Milton Park
OX14 4RQ Abingdon
United Kingdom
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 2 496 960,38